Literature DB >> 20723974

Are SRC family kinases responsible for imatinib- and dasatinib-resistant chronic myeloid leukemias?

Yaoyu Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20723974     DOI： 10.1016/j.leukres.2010.07.032

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  3 in total

Review 1.  Targeting Src family kinases in anti-cancer therapies: turning promise into triumph.

Authors:  Siyuan Zhang; Dihua Yu
Journal:  Trends Pharmacol Sci       Date:  2011-12-09       Impact factor: 14.819

Review 2.  Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.

Authors:  Ashleigh R Poh; Robert J J O'Donoghue; Matthias Ernst
Journal:  Oncotarget       Date:  2015-06-30

3.  Src Family Kinase Inhibitor PP2 Has Different Effects on All-Trans-Retinoic Acid or Arsenic Trioxide-Induced Differentiation of an Acute Promyelocytic Leukemia Cell Line.

Authors:  Suk-Gu Yoon; Hee-Jeong Cheong; Sook-Ja Kim; Kyoung Ha Kim; Sang-Cheol Lee; Namsu Lee; Hee Sook Park; Jong-Ho Won
Journal:  Cancer Res Treat       Date:  2013-06-30       Impact factor: 4.679
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.